PARKMAN HEALTHCARE PARTNERS LLC
Adviser information for PARKMAN HEALTHCARE PARTNERS LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 9 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 6 | $942.5M |
Non-Discretionary | 0 | $0 |
Total | 6 | $942.5M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 6 | $942.5M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 67 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
700 CANAL STREET2ND FLOOR
STAMFORD
CT
United States
Monday - Friday, 9AM - 5PM
Tel: (203) 516-3690, Fax: None
Chief Compliance Officer
MICHAEL ELGORT
CHIEF FINANCIAL OFFICER / CHIEF OPERATING OFFICER
700 CANAL STREET
2ND FLOOR
STAMFORD
CT
United States
Tel:
(203) 516-3704
M******@************M
(Full email address available in API data)
Industry Affiliates
PARKMAN HP FUND GP LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
PARKMAN VENTURE PARTNERS GP LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
PARKMAN HP MASTER FUND LP | Hedge Fund | $356.3M | $1.0M | 39 |
PARKMAN VENTURE PARTNERS SPV I LP | Private Equity Fund | $6.0M | $0.1M | 12 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
ELGORT, MICHAEL, EVAN | Individual | – | CHIEF FINANCIAL OFFICER / CHIEF COMPLIANCE OFFICER / CHIEF OPERATING OFFICER | 01/2019 | < 5% |
PARKMAN HEALTHCARE PARTNERS HOLDINGS LP | Domestic Entity | – | SOLE OWNER | 11/2018 | > 75% |
MARTINEZ, GREGORY, ARTHUR | Individual | – | CHIEF INVESTMENT OFFICER | 11/2018 | < 5% |
MARTINEZ, GREGORY, ARTHUR | Individual | PARKMAN HEALTHCARE PARTNERS HOLDINGS LP | LIMITED PARTNER | 11/2018 | 50-75% |
PARKMAN HEALTHCARE PARTNERS HOLDINGS GP LLC | Domestic Entity | PARKMAN HEALTHCARE PARTNERS HOLDINGS LP | GENERAL PARTNER | 03/2019 | |
MARTINEZ, GREGORY, ARTHUR | Individual | PARKMAN HEALTHCARE PARTNERS HOLDINGS GP LLC | MANAGING MEMBER | 03/2019 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABBOTT LABS | COM | 13M | 122K | – |
AGIOS PHARMACEUTICALS INC | COM | 19M | 446K | – |
AKOYA BIOSCIENCES INC | COM | 879K | 376K | – |
ALPHA TEKNOVA INC | COM | 406K | 297K | – |
ALPHATEC HLDGS INC | COM NEW | 9M | 852K | – |
AMICUS THERAPEUTICS INC | COM | 5M | 502K | – |
ANAPTYSBIO INC | COM | 6M | 256K | – |
ANNEXON INC | COM | 2M | 327K | – |
APPLIED THERAPEUTICS INC | COM | 5M | 1M | – |
ARCELLX INC | COMMON STOCK | 9M | 157K | – |
ARCUS BIOSCIENCES INC | COM | 6M | 416K | – |
ARDELYX INC | COM | 1M | 150K | – |
ARVINAS INC | COM | 3M | 125K | – |
AUGMEDIX INC | COM | 499K | 567K | – |
AVADEL PHARMACEUTICALS PLC | COM SHS | 5M | 378K | – |
AVID BIOSERVICES INC | COM | 4M | 621K | – |
BECTON DICKINSON & CO | COM | 16M | 68K | – |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 11M | 535K | – |
BIOCRYST PHARMACEUTICALS INC | COM | 2M | 400K | – |
BOSTON SCIENTIFIC CORP | COM | 42M | 552K | – |
BRISTOL-MYERS SQUIBB CO | COM | 8M | 200K | – |
CASTLE BIOSCIENCES INC | COM | 6M | 278K | – |
CENCORA INC | COM | 9M | 38K | – |
COOPER COS INC | COM | 27M | 308K | – |
CRINETICS PHARMACEUTICALS IN | COM | 6M | 141K | – |
CVRX INC | COM | 5M | 448K | – |
DAY ONE BIOPHARMACEUTICALS I | COM | 13M | 909K | – |
DEXCOM INC | COM | 18M | 157K | – |
DYNAVAX TECHNOLOGIES CORP | COM NEW | 2M | 217K | – |
EDGEWISE THERAPEUTICS INC | COM | 10M | 575K | – |
ELANCO ANIMAL HEALTH INC | COM | 2M | 126K | – |
ELEVANCE HEALTH INC | COM | 15M | 28K | – |
ELI LILLY & CO | COM | 29M | 32K | – |
ENTERA BIO LTD | SHS | 739K | 402K | – |
ESPERION THERAPEUTICS INC NE | COM | 3M | 1M | – |
ESSA PHARMA INC | COM NEW | 1M | 252K | – |
ETON PHARMACEUTICALS INC | COM | 833K | 253K | – |
FORTREA HLDGS INC | COMMON STOCK | 4M | 153K | – |
GILEAD SCIENCES INC | COM | 9M | 125K | – |
HAEMONETICS CORP MASS | COM | 6M | 76K | – |
HUMANA INC | COM | 11M | 30K | – |
ICON PLC | SHS | 12M | 37K | – |
INARI MED INC | COM | 9M | 196K | – |
INSMED INC | COM PAR $.01 | 5M | 80K | – |
INSULET CORP | COM | 36M | 179K | – |
INTRA-CELLULAR THERAPIES INC | COM | 13M | 185K | – |
IONIS PHARMACEUTICALS INC | COM | 8M | 162K | – |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 6M | 876K | – |
KEROS THERAPEUTICS INC | COM | 9M | 199K | – |
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 12M | 647K | – |
LIVANOVA PLC | SHS | 5M | 85K | – |
LONGBOARD PHARMACEUTICALS IN | COM | 19M | 694K | – |
MANNKIND CORP | COM NEW | 13M | 2M | – |
MERCK & CO INC | COM | 12M | 100K | – |
MERUS N V | COM | 3M | 45K | – |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 4M | 101K | – |
NEUROCRINE BIOSCIENCES INC | COM | 16M | 115K | – |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 3M | 135K | – |
NURIX THERAPEUTICS INC | COM | 10M | 475K | – |
NUVALENT INC | COM | 3M | 43K | – |
PERFORMANT FINL CORP | COM | 5M | 2M | – |
QIAGEN NV | SHS NEW | 10M | 234K | – |
QUANTERIX CORP | COM | 2M | 176K | – |
REPLIMUNE GROUP INC | COM | 5M | 525K | – |
REVIVA PHARMACEUTCLS HLDGS I | COM | 646K | 505K | – |
RXSIGHT INC | COM | 18M | 297K | – |
SCHRODINGER INC | COM | 14M | 721K | – |
SI-BONE INC | COM | 2M | 153K | – |
SILENCE THERAPEUTICS PLC | ADS | 6M | 290K | – |
SUTRO BIOPHARMA INC | COM | 5M | 2M | – |
SYNDAX PHARMACEUTICALS INC | COM | 12M | 601K | – |
TELA BIO INC | COM | 460K | 98K | – |
TENET HEALTHCARE CORP | COM NEW | 20M | 149K | – |
TERNS PHARMACEUTICALS INC | COM | 3M | 390K | – |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 6M | 354K | – |
TG THERAPEUTICS INC | COM | 3M | 180K | – |
THIRD HARMONIC BIO INC | COM | 2M | 133K | – |
TRAVERE THERAPEUTICS INC | COM | 8M | 970K | – |
ULTRAGENYX PHARMACEUTICAL IN | COM | 4M | 100K | – |
UNITED THERAPEUTICS CORP DEL | COM | 35M | 111K | – |
UROGEN PHARMA LTD | COM | 5M | 274K | – |
VAXCYTE INC | COM | 11M | 150K | – |
VENTYX BIOSCIENCES INC | COM | 3M | 1M | – |
VERACYTE INC | COM | 5M | 209K | – |
VERONA PHARMA PLC | SPONSORED ADS | 9M | 595K | – |
VIKING THERAPEUTICS INC | COM | 1M | 20K | – |
VYNE THERAPEUTICS INC | COM | 680K | 345K | – |
X4 PHARMACEUTICALS INC | COM | 468K | 807K | – |
XENON PHARMACEUTICALS INC | COM | 8M | 209K | – |
XERIS BIOPHARMA HOLDINGS INC | COM | 227K | 101K | – |